West Pharmaceutical Services (NYSE:WST) said today that it finished a 60,000 square foot expansion of its contract manufacturing facility near Mulhuddart, County Dublin in Ireland. The expansion is a response to customer demand for medical device manufacturing, especially in the area of diabetes, the company reported.
West anticipates 100 new jobs will be added to the business over 5 years because of the expansion. Additional capacity in Dublin will grow the company’s medical device contract manufacturing business, focusing on molding and assembly solutions for the production of medical devices like auto-injectors and glucose monitoring systems.
The company also said that its contract manufacturing business, which was formerly known as The Tech Group, will align with the West brand.